Cargando…
751. Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory
BACKGROUND: There are not established clinical breakpoints (CBP) for antifungals against Cryptococcus species; However, the analysis of their MICs using epidemiological cut-off values (ECVs) can help to distinguish wild-type (WT) isolates from non-WT strains that may harbor intrinsic or acquired res...
Autores principales: | Ordaya, Eloy E, Abu Saleh, Omar M, Vergidis, Paschalis, Deml, Sharon, Wengenack, Nancy, Fida, Madiha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751563/ http://dx.doi.org/10.1093/ofid/ofac492.036 |
Ejemplares similares
-
The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
por: Ordaya, Eloy E., et al.
Publicado: (2023) -
Utility of Mycobacterium tuberculosis PCR in ruling out active disease and impact on isolation requirements in a low prevalence setting
por: Hamdi, Ahmed, et al.
Publicado: (2020) -
755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
por: Gupta, Aanchal, et al.
Publicado: (2022) -
Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis
por: Ordaya, Eloy E, et al.
Publicado: (2022) -
Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
por: Ordaya, Eloy E., et al.
Publicado: (2023)